Lenalidomide after Stem-Cell Transplantation for Multiple MyelomaPhilip L. McCarthy, Charles Linker, Luis Isola et al.|New England Journal of Medicine|2012Cited by 1.1k
Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Susanna Jacobus et al.|New England Journal of Medicine|2022Cited by 457
GPRC5D-Targeted CAR T Cells for MyelomaSham Mailankody, Eric L. Smith, Sean M. Devlin et al.|New England Journal of Medicine|2022Cited by 383
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple MyelomaOla Landgren, Neha Korde, Malin Hultcrantz et al.|JAMA Oncology|2021Cited by 119
Minimal residual disease in multiple myeloma: bringing the bench to the bedsideSham Mailankody, Ola Landgren, Neha Korde et al.|Nature Reviews Clinical Oncology|2015Cited by 114